Page 5 - SIMPOSIO BETA | Testosterona

Dr. Pablo Carpintero
REFERENCIAS BIBLIOGRAFICAS SIMPOSIO ANDROLONE:
• Davis SR. Not just sex: other roles for testosterone in women. Climacteric. 2025 Jan 17. doi:10.1080/13697137.2024.2445301
• Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, et al. International Society for the Study of Women’s Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women. Climacteric. 2021;24(6):533–50. doi:10.1080/13697137.2021.1891773
• Uloko M, Rahman F, Puri LI, Rubin RS. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review. Int J Impot Res. 2022. doi:10.1038/s41443-022-00613-0
• Vallejo MS, Palacios S. Testosterone in women: beyond hypoactive sexual desire. Gynecol Endocrinol. 2025;41(1):2592402. doi:10.1080/09513590.2025.2592402
• Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660–6. doi:10.1210/jc.2019-01603
Dra. Silvina Valente
• Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-6. doi:10.1210/jc.2019-01603.
• Jang C, Boyle JA, Vincent A. Global consensus statement on testosterone therapy for women: an Australian perspective. Med J Aust. 2020;213(10):449-53. doi:10.5694/mja2.50837.
• Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, et al. International Society for the Study of Women’s Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women. Climacteric. 2021;24(6):533-50. doi:10.1080/13697137.2021.1891773.
• British Menopause Society. Consensus statement: Bioidentical hormone replacement therapy. London: BMS; 2024.
Dra. Prof. Alejandra Belardo
• Pilnik S, Belardo A, Bandeira Marchesan L, Camero-Lascano A, Acuña-San Martín M, Elizalde-Cremonte A, et al. Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG). Climacteric. 2025;28(5). doi:10.1080/13697137.2025.2548805.
• Kling JM. Clinical role of testosterone in menopausal women with HSDD. Obstet Gynecol. 2025;146(3):343–352. doi:10.1097/AOG.0000000000005574.
DATO FDA:
Eliminación por parte de la FDA del Black Box Warning histórica sobre el riesgo cardiovascular y cáncer en terapias hormonales usadas en menopausia
www.fda.gov/news-events/press-announcements/hhs-advances-wom- ens-health-removes-misleading-fda-warnings-hormone-replacement-therapy